Introduction
Becton Dickinson (BD) is a medical technology company that manufactures and sells medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD employs 43,000 people worldwide and has an annual revenue of U.S.$ 15.6 billion.
Becton Dickinson (BD) was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson.
- Becton Dickinson (BD) was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson.
- BD is a medical technology company that manufactures and sells medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
BD is a medical technology company that manufactures and sells medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
BD is a global medical technology company that manufactures and sells medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
BD’s Medical Systems segment provides integrated systems for blood collection, processing and transfusion; equipment for blood cell harvesting procedures such as apheresis; diagnostic testing devices for transfusion medicine; surgical instruments for minimally invasive surgery; ultrasound devices for vascular access procedures in hospitals; imaging agents for use with ultrasound or computed tomography scans at the point of care (POC); diagnostic kits used by physicians to diagnose diseases using urine sample analysis; contrast agents used during MRI scans to highlight tissues inside the body; hemodialysis systems (dialyzers) that filter blood from patients’ blood vessels through an external machine when their kidneys no longer work properly due to disease or injury; as well as diagnostics products used in research laboratories around the world.
BD’s Diagnostic Systems segment manufactures test strips used by diabetics to monitor their glucose level on a daily basis. The division also produces immunoassay analyzers designed to measure specific biochemical substances in human body fluids such as serum or urine samples. Immunoassay analyzers are automated machines that perform chemical reactions between antigens (substances produced by invading microorganisms) present in body fluids taken from patients suspected of having certain diseases such as cancer into antibodies against those antigens which will react chemically when placed together under specific conditions defined by an assay protocol known only by BD personnel who will interpret results using proprietary software algorithms programmed into each machine before shipment overseas where they’re sold internationally under license agreements.”
BD employs 43,000 people worldwide and has an annual revenue of U.S.$ 15.6 billion.
Oops! Click Regenerate Content below to try generating this section again.
Products – BD manufactures medical devices for diagnostics, medical research, drug delivery and drug production.
BD manufactures medical devices for diagnostics, medical research, drug delivery and drug production. It also has a large presence in the food safety market.
BD’s product portfolio includes a wide range of products used to detect diseases such as HIV/AIDS (AIDS testing kits), cancer, diabetes and cardiovascular conditions such as stroke and myocardial infarction (commonly known as heart attack). BD’s products are also used for blood tests such as cholesterol levels or thyroid hormone levels; tissue typing; prenatal care; treatment of sexually transmitted diseases including AIDS; family planning; bone marrow transplants; genetic counseling and diagnosis services including paternity testing.
Diagnostic – BD is a market leader in diagnostic products used to detect diseases such as HIV/AIDS (AIDS testing kits), cancer, diabetes and cardiovascular conditions such as stroke and myocardial infarction (commonly known as heart attack).
BD is a market leader in diagnostic products used to detect diseases such as HIV/AIDS (AIDS testing kits), cancer, diabetes and cardiovascular conditions such as stroke and myocardial infarction (commonly known as heart attack).
Medical Device – In 2006, BD acquired C.R. Bard Inc., a manufacturer of stents which are used to open vessels or airways blocked or narrowed because of atherosclerosis or tumours as well as central venous catheters which are commonly used in intensive care units to administer medication.
BD acquired C.R. Bard Inc., a manufacturer of stents which are used to open vessels or airways blocked or narrowed because of atherosclerosis or tumours as well as central venous catheters which are commonly used in intensive care units to administer medication.
Stents are tiny mesh tubes that are inserted into blood vessels and expand to open up blocked passageways, including arteries leading to the heart or brain. It is also used in other parts of the body where there may be blockages due to trauma such as bums and broken bones.
Markets – Health Care Systems : hospitals and clinics; Life Science Research : for use in academic research labs etc.; Clinical Laboratories – for use in the clinical laboratory setting such as pathology labs etc.; Applied Testing : for use at home; Pharmaceutical Systems : for manufacturing pharmaceuticals; Emerging Markets : developing countries where there is a need for affordable lab systems etc.
- Hospitals and Clinics: These markets include hospitals and clinics.
- Life Science Research: This market includes academic research labs, pharmaceutical companies, and other life science companies.
- Clinical Laboratories: These markets include pathology labs, blood banks, and other clinical laboratories that require diagnostic testing services.
- Applied Testing : BD’s Applied Testing business provides products to be used at home by consumers or in small-scale applications such as restaurants, food manufacturers or farmers’ fields where there is typically no trained technician present.
Conclusion
BD is a leader in the global healthcare industry. Their products and services are used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. The company has been around since 1897 when it was founded by Maxwell W. Becton and Fairleigh S. Dickinson who were also responsible for creating the first portable dialysis machine in 1958 called “The HemoHemo” which revolutionized renal care worldwide. BD’s mission statement reads: “We strive to create innovative medical devices that enhance patient care while providing value for our customers and shareholders.”
Also Read More Articles Below:
Bed Bath & Beyond Business Model
Berkshire Hathaway Business Model
